Improved Differentiation of Mesenchymal Stem Cells into Hepatocyte-like Cells using FGF4 and IGF-1 in 3D Culture
Journal Title: International Journal of Stem Cell Research and Transplantation (IJST) - Year 2015, Vol 3, Issue 4
Abstract
Human Umbilical Cord Mesenchymal Stem Cells (UCMSCs) are considered as an excellent candidate for cell therapy to treat end-stage liver disease. Fibroblast Growth Factor-4 (FGF4), Hepatocyte Growth Factor, and Insulin-like Growth Factor-1 are some of the critical cytokines involved in liver development and regeneration. To evaluate the differentiation potency of cells into hepatocyte-like cells we used these cytokines. UCMSCs were isolated from Wharton's jelly of fullterm infants. The cells were characterized as MSCs by flow-cytometry and their multilineage differentiation capacity. Then, UCMSCs were cultured in 3D collagen scaffold and hepatogenic media with or without FGF4 for 21 days and the data were compared to control. The expression of liver specific genes was evaluated by real-time quantitative RT-PCR and immunocytochemistry. These cells expressed MSC markers and could differentiate into adipocytes and osteocytes. A non–significant higher level of liver specific genes, such as cytokeratin-18 and 19, alpha-fetoprotein and albumin, and also a significant higher level of CYP2B6 expressed by UCMSCs in hepatogenic medium containing FGF4 compared with control. In some specimens, cytokeratin-19-positive cells surrounded a luminal space within collagen scaffolds. Liver-specific marker expression was increased by pre-exposing the cells to FGF4 before treating with IGF-1 and HGF in 3D collagen scaffold.
Authors and Affiliations
Tahereh Talaei-Khozani
Keywords
Related Articles
- EP ID EP197084
- DOI 10.19070/2328-3548-1500018
- Views 98
- Downloads 0
Human Umbilical Cord Matrix - Derived Stem Cells Show Tropism Towards the Human Glioma Microenvironment
Objective: Glioblastoma multiforme (GBM) is an aggressive type of brain tumor in humans. The median survival of patients is a year after diagnosis. It is a great challenge to identify new therapeutic strategies that coul...
Therapy for Lysosomal Storage Disorders: a Matter for Stem Cells
Therapy for Lysosomal Storage Disorders: a Matter for Stem Cells
Obtaining Mesenchymal Stem Cells From Adipose Tissue Of Murin Origin: Experimental Study
The aim of this study was to isolate and characterize rat Adipose Derived Mesenchymal Stem Cells (AD-MSCs) in order to evaluate their proliferative potential and their ability to differentiate in different cell types. AD...
Vascular Regenerative Surgery: Promised Land for Tissue Engineers?
Cardiovascular cell therapy is a promising new field for the development of treatments for cardiovascular diseases, which remain a major cause of mortality around the world. In this review, we highlight the options curre...
Indirect Co-Culture with Schwann Cells as a New Approach for Human Endometrial Stem Cells Neural Transdifferentiation
Neurodegenerative diseases such as Spinal Cord Injury (SCI) refer to the loss of neuronal cells in the central nervous system. Cell replacement therapy is currently the most propitious approach for the treatment of such...